دورية أكاديمية

Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.

التفاصيل البيبلوغرافية
العنوان: Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas.
المؤلفون: Pareja, Fresia, Toss, Michael S, Geyer, Felipe C, Silva, Edaise M, Vahdatinia, Mahsa, Sebastiao, Ana Paula M, Selenica, Pier, Szatrowski, Austin, Edelweiss, Marcia, Wen, Hannah Y, Mihai, Raluca, Varga, Zsuzsanna, Foschini, Maria P, Rubin, Brian P, Ellis, Ian O, Chandarlapaty, Sarat, Jungbluth, Achim A, Brogi, Edi, Weigelt, Britta, Reis‐Filho, Jorge S
المصدر: Histopathology; May2020, Vol. 76 Issue 6, p865-874, 10p, 2 Color Photographs, 1 Black and White Photograph, 1 Chart, 1 Graph
مصطلحات موضوعية: BREAST, GLUTAMATE receptors, CONTENT analysis, MONOCLONAL antibodies
مصطلحات جغرافية: AMES (Iowa)
مستخلص: Aims: Breast adenomyoepitheliomas (AMEs) are uncommon tumours. Most oestrogen receptor (ER)‐positive AMEs have mutations in phosphoinositide 3‐kinase (PI3K) pathway genes, whereas ER‐negative AMEs usually harbour concurrent mutations affecting the HRAS Q61 hotspot and PI3K pathway genes. Here, we sought to determine the sensitivity and specificity of RAS Q61R immunohistochemical (IHC) analysis for detection of HRAS Q61R mutations in AMEs. Methods and results: Twenty‐six AMEs (14 ER‐positive; 12 ER‐negative) previously subjected to massively parallel sequencing (n = 21) or Sanger sequencing (n = 5) of the HRAS Q61 hotspot locus were included in this study. All AMEs were subjected to IHC analysis with a monoclonal (SP174) RAS Q61R‐specific antibody, in addition to detailed histopathological analysis. Nine ER‐negative AMEs harboured HRAS mutations, including Q61R (n = 7) and Q61K (n = 2) mutations. Five of seven (71%) AMEs with HRAS Q61R mutations were immunohistochemically positive, whereas none of the AMEs lacking HRAS Q61R mutations (n = 17) were immunoreactive. RAS Q61R immunoreactivity was restricted to the myoepithelium in 80% (4/5) of cases, whereas one case showed immunoreactivity in both the epithelial component and the myoepithelial component. RAS Q61R immunohistochemically positive AMEs were associated with infiltrative borders (P < 0.001), necrosis (P < 0.01) and mitotic index in the epithelial (P < 0.05) and myoepithelial (P < 0.01) components. RAS Q61R IHC assessment did not reveal Q61K mutations (0/2). Conclusions: IHC analysis of RAS Q61R shows high specificity (100%) and moderate sensitivity (71%) for detection of HRAS Q61R mutations in breast AMEs, and appears not to detect HRAS Q61K mutations. IHC analysis of RAS Q61R may constitute a useful technique in the diagnostic workup of ER‐negative AMEs. [ABSTRACT FROM AUTHOR]
Copyright of Histopathology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:03090167
DOI:10.1111/his.14057